Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Washingtonian: Washington DC’s 500 Most Influential People of 2025
David Mitchell – Patients for Affordable Drugs Now – President and Founder Mitchell runs the bipartisan national organization focused on ways to lower drug prices, including marshaling patients to pressure lawmakers and testifying on Capitol Hill. Hometown: Detroit. First job: “Drugstore clerk for 67 cents per hour at 14 years of age.” What he’d tell his 18-year-old self: […]
News and Reports
Pharmaphorum: How Trump's pharma tariffs will hurt industry and patients alike
“Ninety percent of medications or prescriptions that are filled here in the US are generics,” Merith Basey, executive director of Patients for Affordable Drugs Now, told Deep Dive. “Generics are the ones, obviously, that we’re most concerned about, given that they operate on limited margins and these increases could substantially increase the cost for patients.”
Press Releases
To our Community, Today marks one hundred days into the new presidential administration. A key moment to take stock and reflect on where we are in the fight to lower drug prices for all Americans. Over the past several weeks, we’ve heard directly from nearly 1,000 people in our community – patients, family members, caregivers […]
News and Reports
Merith Basey (Patients for AffordableDrugs, Washington, DC,USA) told The Lancet Oncology that she was particularly concerned about what she called a “poison pill” part of Trump’s executive order that orders a potential change in how some drugs are costed. Under a law brought in under the Biden administration, Medicare can negotiate the price of some […]
News and Reports
Patients for Affordable Drugs, a patient advocacy organization, called the provision on the negotiation program “deeply harmful.” “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma. It would hand drug companies four additional years to price-gouge patients, one in three of whom can’t afford […]
News and Reports
Fierce Healthcare: Trump order seeks changes to Medicare drug price negotiation program, PBM reform
The provision’s inclusion was not supported by Patients for Affordable Drugs, calling it a “deeply harmful” item that caves to pharmaceutical lobbyists. “It would hand drug companies four additional years to price-gouge patients, one in three of whom can’t afford their prescription drugs today,” said Executive Director Merith Basey. “This change isn’t about supporting innovation […]
News and Reports
Healthcare Finance: Trump's executive order on drugs seeks to end pharma 'pill penalty'
Merith Basey, executive director of Patients For Affordable Drugs, said the small molecule provision in the EO caves to pharmaceutical lobbyists’ demands. “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma,” Basey said. “It would hand drug companies four additional years to price-gouge patients, […]